Your session is about to expire
← Back to Search
Rhythmically Enhanced Music Exercise Program for COPD
Study Summary
This trial is testing a home-based exercise program for Veterans with COPD, to see if it is more effective than current hospital-based rehab.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have severe heart failure (NYHA Class III or IV).I have not had a lung infection or COPD flare-up in the last month.I have severe heart failure as a COPD patient.I have COPD and must stop walking because of leg pain.I stop exercising because of knee or hip pain from arthritis.My lung function is less than 70% of the expected.I was hospitalized or visited the ER for COVID-19.I can walk more than 550 meters in 6 minutes.I have heart disease that limits my ability to exercise.I experience chest pain when walking or have signs of heart disease limiting my exercise.I have heart disease that limits my ability to exercise.I have COPD and my leg arteries limit my ability to exercise.I am 40 years old or younger with COPD.My oxygen level stays around 88% when I exercise.I am 18 years old or older and have COVID-19.I can walk by myself despite having COVID-19.My oxygen level drops to 88% or lower when I exercise.I have COPD and cannot walk on a treadmill.I have COPD and have shown signs of heart disease or experienced chest pain during a stress test.I stop exercising because of knee or hip pain.I have COPD and have been part of an exercise program in the last 3 months.I have COPD and no conditions that prevent me from doing exercise tests or training.I stop exercising because of leg pain from poor circulation.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
- Group 1: RAS-music group
- Group 2: Control group
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
Frequently Asked Questions
How many people are currently enrolled in this clinical trial?
"That is correct. Currently, the clinical trial is recruiting patients. The listing was first created on October 1st, 2018 and updated February 18th, 2022. They are looking for a total of 170 individuals from 1 site."
What are the risks associated with using rhythmically auditory stimulation enhanced music for patients?
"There is some evidence from earlier trials to support the efficacy of rhythmically auditory stimulation enhanced music, and it has been through multiple rounds of testing to ensure safety. This gave it a score of 3 on our Power team's scale."
Are new participants being accepted into this clinical trial?
"This trial, which was created on October 1st 2018 and last updated February 18th 2022, is still recruiting patients according to the clinicaltrials.gov website."
Who else is applying?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Share this study with friends
Copy Link
Messenger